TGFB1 and cancer: Especially, although the WNT (IWR-1) and TGF-β (SB431542) pathway inhibitors impaired the cancer-promoting effects of CFP1 overexpression, they more intensively inhibited the growth of negative control cells (Fig. 6j–o).